AI-based drug discovery company Recursion raises $121M at a $646M valuation; VCs invested about $1B in AI drug discovery startups in 2018, up from $237M in 2016 Robert Langreth / Bloomberg : Bloomberg 2019-07-16 Robert Langreth VCs, Robert Langreth Related Coverage View article Axios View article Recursion Pharmaceuticals View article FierceBiotech View article Business Insider View article Financial Times